CytomX Therapeutics (CTMX) PT Raised to $3.20 at BMO Capital
Tweet
Share
E-mailGet Alerts CTMX Hot Sheet
Price: $2.78 -5.44%
Rating Summary:
14 Buy, 4 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 6 | New: 39
Rating Summary:
14 Buy, 4 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 6 | New: 39
Join SI Premium – FREE
BMO Capital analyst Etzer Darout raised the price target on CytomX Therapeutics (NASDAQ: CTMX) to $3.20 (from $2.60) while maintaining a Market Perform rating.
You May Also Be Interested In
- Sandvik AB (SAND:SS) (SDVKY) PT Raised to SEK440 at Rothschild Redburn
- Alamtri Minerals Indonesia (ADMR:IJ) PT Lowered to IDR2,230 at JPMorgan
- Evolution Mining Ltd. (EVN:AU) (CAHPF) PT Lowered to AUD12.50 at RBC Capital
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
